{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:58:51Z","timestamp":1781153931307,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier","isbn-type":[{"value":"9780443428692","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033\/FEDER"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033\/FEDER"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2022\\u2013136799OB-I00"],"award-info":[{"award-number":["PID2022\\u2013136799OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN\/AEI\/655"],"award-info":[{"award-number":["MCIN\/AEI\/655"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010067","name":"Gobierno de Arag\u00f3n","doi-asserted-by":"publisher","award":["B31_20R"],"award-info":[{"award-number":["B31_20R"]}],"id":[{"id":"10.13039\/501100010067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010067","name":"Gobierno de Arag\u00f3n","doi-asserted-by":"publisher","award":["B31_23R"],"award-info":[{"award-number":["B31_23R"]}],"id":[{"id":"10.13039\/501100010067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.mcb.2026.02.008","type":"book-chapter","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:30:03Z","timestamp":1772022603000},"page":"85-97","source":"Crossref","is-referenced-by-count":0,"title":["Flow cytometry evaluation of cytotoxicity exerted by effector immune cells against tumor cells"],"prefix":"10.1016","author":[{"given":"Cristina","family":"Ripoll\u00e9s-Yuba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Giraldos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Galano-Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Reina-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Anel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/bs.mcb.2026.02.008_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc3907","article-title":"Haematological malignancies: At the forefront of immunotherapeutic innovation","volume":"15","author":"Bachireddy","year":"2015","journal-title":"Nature Reviews. Cancer"},{"issue":"8","key":"10.1016\/bs.mcb.2026.02.008_bib2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3324\/haematol.2011.041301","article-title":"Phenotypic and functional evaluation of CD3+CD4-CD8- T cells in human CD8 immunodeficiency","volume":"96","author":"Bernardo","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/bs.mcb.2026.02.008_bib3","first-page":"181","article-title":"Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs","volume":"14","author":"Brunner","year":"1968","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76051-z","article-title":"Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance","volume":"10","author":"Calvo","year":"2020","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2559782","article-title":"NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells ex vivo and in vivo, especially if combined with daratumumab","volume":"14","author":"Giraldos","year":"2025","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/bs.mcb.2026.02.008_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ijc.34243","article-title":"Therapy resistance mechanisms in hematological malignancies","volume":"152","author":"Hofmann","year":"2023","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1016\/bs.mcb.2026.02.008_bib7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/s41596-020-00467-0","article-title":"Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity","volume":"16","author":"Kiesgen","year":"2021","journal-title":"Nature Protocols"},{"issue":"1\u20132","key":"10.1016\/bs.mcb.2026.02.008_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-1759(96)00194-9","article-title":"Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity","volume":"200","author":"Konjevi\u0107","year":"1997","journal-title":"Journal of Immunological Methods"},{"issue":"3","key":"10.1016\/bs.mcb.2026.02.008_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(83)90438-6","article-title":"An enzyme-release assay for natural cytotoxicity","volume":"64","author":"Korzeniewski","year":"1983","journal-title":"Journal of Immunological Methods"},{"issue":"10","key":"10.1016\/bs.mcb.2026.02.008_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nature Reviews. Cancer"},{"issue":"13","key":"10.1016\/bs.mcb.2026.02.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202207475","article-title":"Immunogenic cell death in hematological malignancy therapy","volume":"10","author":"Liu","year":"2023","journal-title":"Advanced Science"},{"issue":"9","key":"10.1016\/bs.mcb.2026.02.008_bib12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nprot.2009.143","article-title":"Expression, purification and use of recombinant annexin V for the detection of apoptotic cells","volume":"4","author":"Logue","year":"2009","journal-title":"Nature Protocols"},{"issue":"6","key":"10.1016\/bs.mcb.2026.02.008_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/CDLI.8.6.1131-1135.2001","article-title":"Calcein-acetyoxymethyl cytotoxicity assay: Standardization of a method allowing additional analyses on recovered effector cells and supernatants","volume":"8","author":"Neri","year":"2001","journal-title":"Clinical Diagnostic Laboratory Immunology"},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40164-025-00684-x","article-title":"Global burden and trends of hematologic malignancies based on global cancer observatory 2022 and global burden of disease 2021","volume":"14","author":"Pan","year":"2025","journal-title":"Experimental Hematology & Oncology"},{"key":"10.1016\/bs.mcb.2026.02.008_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jim.2014.01.012","article-title":"An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells","volume":"405","author":"Peper","year":"2014","journal-title":"Journal of Immunological Methods"},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/hum.2008.068","article-title":"Chimeric Receptor mRNA transfection as a tool to generate antineoplastic lymphocytes","volume":"20","author":"Rabinovich","year":"2009","journal-title":"Human Gene Therapy"},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1853314","article-title":"Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients","volume":"10","author":"Reina-Ortiz","year":"2021","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/bs.mcb.2026.02.008_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/cells11030392","article-title":"Harnessing the potential of NK cell-based immunotherapies against multiple myeloma","volume":"11","author":"Reina-Ortiz","year":"2022","journal-title":"Cells"},{"issue":"14","key":"10.1016\/bs.mcb.2026.02.008_bib19","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.7150\/thno.25149","article-title":"Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors","volume":"8","author":"Sanchez-Martinez","year":"2018","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/bs.mcb.2026.02.008_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.mcb.2026.02.008_bib21","unstructured":"Sociedad Espa\u00f1ola de Inmunolog\u00eda; Grupo de Inmunoterapia (GEIT). (2025). Gu\u00eda de recomendaciones para la monitorizaci\u00f3n de terapias CAR-T. https:\/\/www.inmunologia.org\/images\/site\/guias\/GUIA_MONITORIZACION_CART_GEIT.pdf."},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41392-023-01521-5","article-title":"Immunotherapy in hematologic malignancies: Achievements, challenges and future prospects","volume":"8","author":"Tang","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"April","key":"10.1016\/bs.mcb.2026.02.008_bib23","first-page":"1","article-title":"ADCC: The rock band led by therapeutic antibodies, tumor and immune cells","volume":"16","author":"Vincken","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer Journal"},{"issue":"February","key":"10.1016\/bs.mcb.2026.02.008_bib25","first-page":"1","article-title":"CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies","volume":"14","author":"Zhang","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"June","key":"10.1016\/bs.mcb.2026.02.008_bib26","first-page":"1","article-title":"CAR-T cell therapy in hematological malignancies: Current opportunities and challenges","volume":"13","author":"Zhang","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40164-024-00536-0","article-title":"CAR-T cell combination therapies in hematologic malignancies","volume":"13","author":"Zhou","year":"2024","journal-title":"Experimental Hematology & Oncology"},{"issue":"1","key":"10.1016\/bs.mcb.2026.02.008_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-025-02269-w","article-title":"CAR-T cell therapy for cancer: Current challenges and future directions","volume":"10","author":"Zugasti","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"}],"container-title":["Methods in Cell Biology","Cell Death \u2013 Part C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X26000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X26000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:21:19Z","timestamp":1781151679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X26000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443428692"],"references-count":28,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2026.02.008","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}